Feb 18, 2019 - Merck's (MRK) sBLA looking for approval of Keytruda plus Pfizer's Inlyta for the first-line treatment of the most common type of kidney cancer gets FDA's priority review.
Feb 15, 2019 - Hrt Financial Llc Buys iShares Inc MSCI Brazil, VanEck Vectors Gold Miners, iShares China Large-Cap, Sells SPDR S&P 500, Amazon.com Inc, Marathon Petroleum Corp, Stocks: EWZ,GDX,FXI,GDXJ,WFC,PFE,AVGO,TVIX,MRK,D,AVT,CI,AM, release date:Feb 15, 2019
Feb 15, 2019 - FDA accepts Sarepta's (SRPT) regulatory application seeking approval for DMD therapy, golodirsen, and grants priority review. A decision is expected in August 2019.
Feb 13, 2019 - Exelixis's (EXEL) earnings and revenues beat expectations in the fourth quarter on strong sales of Cabometyx.
Feb 12, 2019 - Bristol-Myers' (BMY) oncology drug, Sprycel in combination with chemotherapy gets EC approval to treat pediatric patients with newly diagnosed Ph+ ALL.
Feb 12, 2019 - Pfizer (PFE)/Merck KGaA's label expansion application for Bavencio as a treatment for advanced kidney cancer in combination with Inlyta gets priority review in the United States. The decision is expected in June.
Feb 12, 2019 - Pfizer (NYSE:PFE) and alliance partner Merck KGaA (OTCPK:MKGAY) announce that the FDA has accepted under Priority Review the supplemental marketing application seeking approval for BAVENCIO (avelumab)
Feb 12, 2019 - Markets closed mostly higher on Monday as fresh rounds of trade talks between the United States and China began.
Feb 11, 2019 - Eli Lilly (LLY) to initiate an exchange offer for shareholders to divest its remaining ownership interest in Elanco
Feb 11, 2019 - GSK collaborates with Merck KGaA on M7824, a TGF-beta.M7824 represents a class of agents considered to be the future of Immuno-Oncology.Late stage trials are needed to validate, M7824; if successful,